NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 1,075.35
+4.35 (0.41%)
Apr 23, 2026, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 191.91 billion as of April 23, 2026. Its market cap has increased by 34.14% in one year.
Market Cap
191.91B
Enterprise Value
162.52B
Revenue
45.63B
Ranking
n/a
PE Ratio
12.32
Stock Price
1,075.35
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 191.91B, an increase of 44,593.15%. That is a compound annual growth rate of 25.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 191.83B | 18.60% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 379.24B |
| Ajanta Pharma | 347.09B |
| Emcure Pharmaceuticals | 302.95B |
| Gland Pharma | 296.66B |
| Wockhardt | 235.66B |
| Piramal Pharma | 204.24B |
| Eris Lifesciences | 187.42B |
| Alembic Pharmaceuticals | 150.29B |